Sciencast Management LP Buys New Shares in GE HealthCare Technologies Inc. $GEHC

Key Points

• Sciencast Management LP has acquired a new stake in GE HealthCare Technologies, purchasing 43,633 shares valued at approximately $3.52 million during the first quarter.
• GE HealthCare Technologies reported $1.06 earnings per share for the last quarter, exceeding analysts' estimates of $0.91, along with revenue of $5 billion, surpassing expectations of $4.96 billion.
• The company announced a quarterly dividend of $0.035 per share, with an annual yield of 0.2%, reflecting a dividend payout ratio of 2.87%.

Sciencast Management LP bought a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 43,633 shares of the company's stock, valued at approximately $3,522,000.

Other large investors also recently bought and sold shares of the company. N.E.W. Advisory Services LLC bought a new position in GE HealthCare Technologies during the 1st quarter worth approximately $25,000. Bogart Wealth LLC lifted its holdings in GE HealthCare Technologies by 260.0% during the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock worth $28,000 after buying an additional 247 shares during the last quarter. Stonebridge Financial Group LLC lifted its holdings in GE HealthCare Technologies by 165.7% during the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock worth $29,000 after buying an additional 222 shares during the last quarter. Ameriflex Group Inc. bought a new position in GE HealthCare Technologies during the 4th quarter worth approximately $31,000. Finally, Olde Wealth Management LLC bought a new position in GE HealthCare Technologies during the 1st quarter worth approximately $35,000. Institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Price Performance

GEHC stock traded down $2.72 during midday trading on Wednesday, reaching $75.99. 4,102,538 shares of the company's stock traded hands, compared to its average volume of 2,832,072. The company has a 50-day simple moving average of $74.41 and a two-hundred day simple moving average of $73.85. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The company has a market cap of $34.69 billion, a price-to-earnings ratio of 15.57, a PEG ratio of 3.01 and a beta of 1.13. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, beating analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The firm had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same period last year, the company earned $1.00 EPS. The business's quarterly revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were issued a dividend of $0.035 per share. The ex-dividend date was Friday, July 25th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies's payout ratio is currently 2.87%.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on GEHC shares. Citigroup increased their price target on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research report on Thursday, July 31st. BTIG Research restated a "buy" rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Wall Street Zen upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, May 31st. Zacks Research raised GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 28th. Finally, Morgan Stanley decreased their price target on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a research note on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $88.40.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.